28.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$28.50
Aprire:
$28.45
Volume 24 ore:
386.84K
Relative Volume:
0.67
Capitalizzazione di mercato:
$1.35B
Reddito:
$723.55M
Utile/perdita netta:
$157.72M
Rapporto P/E:
9.4767
EPS:
3
Flusso di cassa netto:
$170.15M
1 W Prestazione:
+0.49%
1M Prestazione:
-9.72%
6M Prestazione:
-40.80%
1 anno Prestazione:
-35.25%
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AMPH
Amphastar Pharmaceuticals Inc
|
28.43 | 1.35B | 723.55M | 157.72M | 170.15M | 3.00 |
![]()
ZTS
Zoetis Inc
|
163.11 | 73.07B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.05 | 47.43B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.24 | 45.72B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.08 | 17.28B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
131.81 | 14.03B | 612.78M | -86.37M | -62.91M | -0.87 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
2024-03-05 | Iniziato | JP Morgan | Overweight |
2023-11-17 | Iniziato | BofA Securities | Neutral |
2023-07-25 | Ripresa | Jefferies | Buy |
2022-10-21 | Ripresa | Jefferies | Buy |
2022-07-29 | Iniziato | CapitalOne | Overweight |
2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
2020-05-01 | Iniziato | Northland Capital | Outperform |
2019-03-13 | Downgrade | Needham | Buy → Hold |
2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
2018-08-10 | Reiterato | Needham | Buy |
2018-03-13 | Reiterato | Needham | Buy |
2017-12-01 | Reiterato | Needham | Buy |
2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
2017-09-27 | Reiterato | Needham | Buy |
2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
2016-08-09 | Reiterato | Needham | Buy |
2016-05-10 | Reiterato | Needham | Buy |
2016-02-19 | Iniziato | Wells Fargo | Outperform |
2015-06-19 | Reiterato | Needham | Buy |
2015-06-03 | Iniziato | Raymond James | Strong Buy |
2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Raymond James Financial Inc. Takes $3.45 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Quantbot Technologies LP Invests $945,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Investment Report - Stock Traders Daily
Fox Run Management L.L.C. Takes $688,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award - ACCESS Newswire
Amphastar Wins FDA Award: How Its Solution to Critical Drug Shortage Signals Major Growth - StockTitan
Intech Investment Management LLC Increases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - MarketBeat
Boston Partners Purchases Shares of 426,636 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Hypoglycemia Pipeline 2025: FDA Approvals, Therapies, - openPR
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by PNC Financial Services Group Inc. - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Amundi - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Piper Sandler Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - Defense World
Charles Schwab Investment Management Inc. Sells 2,544 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar stock target cut to $32 by Piper Sandler, maintains neutral - Investing.com Canada
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amundi Acquires 12,899 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals Inc (AMPH) Shares Up 0.46% on Mar 19 - GuruFocus.com
US Bancorp DE Has $31,000 Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
(AMPH) Pivots Trading Plans and Risk Controls - Stock Traders Daily
On Nasdaq, I Prefer The Less-Famous Stocks - Forbes
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 52-Week LowTime to Sell? - MarketBeat
Wealthfront Advisers LLC Acquires New Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Smartleaf Asset Management LLC Increases Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks | FinancialContent - Financial Content
Amphastar stock hits 52-week low at $26.97 amid market challenges - Investing.com Australia
Amphastar at Barclays Conference: Strategic Focus on Growth and Innovation By Investing.com - Investing.com UK
Amphastar stock hits 52-week low at $26.97 amid market challenges By Investing.com - Investing.com South Africa
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO Sells 4,231 Shares of Stock - MarketBeat
Amphastar Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire
(AMPH) Proactive Strategies - Stock Traders Daily
Amphastar Pharmaceuticals director Petersen sells $27,986 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals director Petersen sells $27,986 in stock - Investing.com India
Amphastar Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Amphastar Pharmaceuticals CFO sells $116,515 in stock By Investing.com - Investing.com Australia
Amphastar Pharmaceuticals CFO sells $116,515 in stock - Investing.com
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):